10-K: SiriusPoint Reports Strong 2025 Results, Strategic Progress

Sentiment:

Annual Report 24 February 2026 5:12 PM

SiriusPoint Ltd. announced significantly improved financial performance for 2025, driven by strategic repositioning, underwriting gains, and successful divestitures.

Capital raiseThe company may need to raise additional capital in the future through offerings of debt or equity securities to fund liquidity needs, replace capital lost from significant losses, satisfy collateral requirements, fund strategic initiatives, meet rating agency/regulatory capital requirements, or respond to competitive pressures.Additional capital raised through equity sales could dilute ownership interest.Additional capital raised through debt issuance may result in more restrictive covenants and senior creditor rights.

Better than expectedNet income available to common shareholders increased significantly to $443.6 million in 2025 from $183.9 million in 2024.Return on average common shareholders equity more than doubled to 22.1% in 2025 from 9.1% in 2024.Core underwriting income grew to $214.3 million in 2025, up from $200.0 million in 2024.Book value per common share increased by 30.0% to $19.40 as of December 31, 2025.The company recognized a substantial gain of $222.4 million from the sale of Armada.

Summary

Net income available to common shareholders increased to $443.6 million in 2025 from $183.9 million in 2024.
Return on average common shareholders equity attributable to SiriusPoint common shareholders rose to 22.1% in 2025 from 9.1% in 2024.
Core underwriting income grew to $214.3 million in 2025 with a combined ratio of 91.7%, compared to $200.0 million and 91.0% in 2024.
Gross written premium increased by 16.1% to $3,705.6 million in 2025, with net written premium up 18.7% to $2,772.8 million.
Investment results remained strong at $271.9 million in 2025, including $274.8 million of net investment income.
The company completed the sale of its wholly-owned subsidiary ArmadaCorp Capital, LLC for $250 million, recognizing a gain of $222.4 million.
SiriusPoint entered into an agreement to acquire Assist America, a global emergency travel assistance provider, effective January 1, 2026.
The company announced the redemption of all outstanding Series B Preference Shares on February 26, 2026, at $25.49 per share.
Book value per common share increased by 30.0% to $19.40 as of December 31, 2025.
The company launched 16 new strategic partnerships with program administrators during 2025.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a very positive report, reflecting strong financial performance, successful execution of strategic initiatives, and a clear path for future growth and capital optimization, despite some market headwinds.

Positives

Net income available to common shareholders significantly increased to $443.6 million in 2025 from $183.9 million in 2024.
Return on average common shareholders equity more than doubled to 22.1% in 2025, up from 9.1% in 2024.
Core underwriting income improved to $214.3 million in 2025, compared to $200.0 million in 2024, reflecting strong underwriting performance.
The core combined ratio remained strong at 91.7% in 2025, indicating disciplined underwriting.
Gross written premium increased by 16.1% to $3,705.6 million in 2025, demonstrating successful business growth.
Net investment income and net realized and unrealized investment losses increased to $271.9 million in 2025 from $224.6 million in 2024.
A gain of $222.4 million was recognized from the sale of ArmadaCorp Capital, LLC, contributing significantly to other revenues.
The acquisition of Assist America is expected to bolster third-party medical and travel assistance revenue and expand global coverage.
The planned redemption of Series B Preference Shares will simplify the capital structure and optimize financial leverage.
Book value per common share increased by $4.48, or 30.0%, to $19.40 as of December 31, 2025.
The company successfully rotated its investment portfolio to reduce volatility and capital intensity, maintaining an average credit rating of AAwith no defaults in 2025.

Negatives

Catastrophe losses increased to $74.4 million in 2025, up from $54.8 million in 2024, primarily due to California wildfires.
Favorable prior year loss reserve development decreased to $73.8 million in 2025 from $107.9 million in 2024.
Foreign exchange losses amounted to $25.2 million in 2025, compared to gains of $10.0 million in 2024.
Net corporate and other expenses increased to $257.0 million in 2025 from $232.1 million in 2024, driven by strategic transactions and service expenses.
Service fee income from consolidated MGAs contracted by 10.5% in 2025 due to the sale of Armada and deconsolidation of Arcadian.

Risks

Ability to execute on strategic transformation, including re-underwriting, de-risking investment portfolio, and business transformation.
Frequency, severity, and development of insured losses, including natural catastrophes, extreme weather events, epidemics, pandemics, and man-made events.
Adequacy, accuracy, and development of pricing or loss and loss adjustment expense reserves.
Lack of available capital and periods characterized by excess underwriting capacity and unfavorable premium rates.
Ability to maintain or improve underwriting discipline, risk selection, and portfolio diversification.
Cyclicality of the insurance and reinsurance markets, including changes in pricing, terms, conditions, and capacity.
Risks relating to the use of reinsurance, retrocessions, alternative capital, and third-party capital arrangements, including counterparty creditworthiness.
Ability to compete successfully in the insurance and reinsurance market and the effect of consolidation.
Operational, cybersecurity, and technology-related risks, including system failures, data breaches, ransomware attacks, and supply chain compromises.
Failures or harmful outputs of AI models, and risks associated with adopting or integrating new AI technologies.
Effects of global climate change, including increased severity and frequency of weather-related natural disasters.
Geopolitical uncertainty, including ongoing conflicts in Europe, South America, and the Middle East.
Risks related to inflation, social inflation, and shifts in judicial, legislative, or regulatory environments.
Ability to attract, develop, and retain key personnel, distribution partners, and underwriting talent.
A downgrade or withdrawal of financial ratings.
Fluctuations in results of operations.
Performance of strategic partnerships, joint ventures, and delegated underwriting authorities, including risks with MGAs.
Legal restrictions on subsidiaries' ability to pay dividends and other distributions.
Outcome of legal and regulatory proceedings.
Reduced returns or losses in the investment portfolio, including market volatility, credit events, interest rate movements, and foreign exchange fluctuations.
Exposure to corporate income tax in Bermuda and the EU, U.S. federal income and withholding taxes, and devaluation of deferred tax assets.
Risks from future strategic transactions such as acquisitions, dispositions, investments, mergers, or joint ventures.
Potential terrorist acts and their material adverse effect on business.
Inability to provide collateral to certain counterparties on commercially acceptable terms.
Inability to service indebtedness, affecting liquidity and financial condition.
Need for additional capital in the future, which may not be available or could dilute ownership.
Reliance on client evaluations of risks when underwriting policies, potentially leading to reinsurance losses.
Credit risk from reinsurance brokers and MGAs.
Inability to purchase or collect on retrocessional coverage.
Risk of becoming an investment company under U.S. federal securities law.
Changes in U.S. healthcare legislation affecting accident and health business.
Failure to meet minimum capital and surplus requirements.
Changes in Bermuda law and regulations, and the political environment in Bermuda.
Future sales of shares by existing shareholders causing share price decline.
Concentrated ownership preventing shareholders from influencing corporate decisions.
Provisions in Bye-Laws discouraging takeovers and business combinations.
Market price fluctuations of common shares.

Future Outlook

The company aims to be a top-performing underwriter with a diverse, low-volatility portfolio of specialty lines, targeting a 12-15% return on equity across the pricing cycle. Global insurance markets are generally softening, with reduced rates of increase, though commercial auto and aviation are experiencing significant rate increases due to poor industry loss experience and severe global aviation losses, respectively. Strong growth is anticipated in the program business, particularly in North America and the U.K., driven by underwriting talent migration to MGAs and a shift to the E&S market. Reinsurance markets are experiencing declining rates due to over-supply and strong financial performance, with property catastrophe reinsurance seeing significant risk-adjusted rate decreases globally, while US casualty remains more stable. Specialty lines generally face rate decreases, except for aviation.

Management Comments

"Our ambition is to drive excellence as a best-in-class underwriter, with a diverse and low-volatility portfolio of specialty lines, that generally targets a 12-15% return on equity across the pricing cycle."
"We strive to maintain a relentless focus on underwriting and a disciplined approach to strategic capital deployment."
"We seek to create capacity partnerships with MGAs that have high integrity and transparent leaders, and teams with deep underwriting expertise and track records of success, and no longer take capital positions in those business partners."
"The redemption will help to simplify and optimize our capital structure and financial leverage, while also eliminating the cost of capital and related cash servicing associated with the Series B preference shares. After the redemption, our capital position will remain at or above operating target levels."

Industry Context

StockSavvy.ai notes SiriusPoint's strategic repositioning towards a lower volatility, specialty lines portfolio aligns with broader industry trends emphasizing underwriting discipline and capital efficiency in a challenging market. The company's increased focus on MGA partnerships and divestiture of non-core assets reflects a common strategy among re/insurers to leverage specialized distribution and streamline operations. The observed softening in global insurance and reinsurance rates, alongside specific hardening in commercial auto and aviation, is consistent with current market cyclicality and loss experience across the sector. The company's strong financial strength ratings from AM Best, Fitch, S&P, and Moody's position it favorably against competitors in a competitive landscape.

Comparison to Industry Standards

SiriusPoint's operating companies maintain financial strength ratings of A(Positive) from AM Best, Fitch Ratings, and Standard & Poor's, and A3 (Stable) from Moody's Ratings. These ratings are generally considered strong within the insurance and reinsurance industry, comparable to well-established global players.
The target return on equity of 12-15% across the pricing cycle is competitive and aligns with the aspirations of top-tier specialty underwriters in the market.
The combined ratio of 91.7% for core business in 2025 demonstrates strong underwriting profitability, comparing favorably to many industry peers who often target combined ratios in the low to mid-90s for specialty lines.
The company's strategy to increase business mix from Other Specialties, MGA, and Accident & Health while reducing Property exposure is a common de-risking approach seen across the industry, aiming for less volatile earnings compared to heavily catastrophe-exposed portfolios.
The use of Loss Portfolio Transfers (LPTs) covering $2.1 billion of reserves to remove risk from exited businesses is a recognized industry practice for capital optimization and risk reduction, similar to actions taken by companies like Enstar Group Limited in managing legacy liabilities.

Management Changes

Role	Previous Person	New Person	Effective Date	Reason
Director	Meng Tee Saw	NA	2025-02-27	Resigned in connection with the closing of the CM Bermuda Securities Purchase Agreement, as CM Bermuda no longer has an ownership interest.
Chief Executive Officer of SiriusPoint International	NA	Rob Gibbs	2022-12-12	Appointment to the role.

Corporate Governance

Change Type	Description	Effective Date	Impact Assessment
Board Structure	Board is divided into three classes (Class I, Class II, Class III) with directors holding office for a three-year term. Changes to the number of directors are apportioned to maintain class equality.	NA	Designed to have an anti-takeover effect by staggering director elections and making it harder to change board composition quickly.
Director Removal	Directors may only be removed for cause by the affirmative vote of holders of at least 50% of voting shares.	NA	Increases director stability and makes it more difficult for shareholders to effect rapid changes to the board.
Shareholder Action	Shareholder action may only be taken at an annual or special general meeting, not by written consent.	NA	Limits shareholder ability to act quickly outside of scheduled meetings, potentially delaying or preventing certain actions.
Shareholder Advance Notice Procedures	Establishes advance notice requirements for shareholder nominations of directors and other business proposals at meetings.	NA	Provides the Board with time to review and respond to shareholder proposals, potentially deterring unsolicited actions.
Amendments to Charter Documents	Amendments to Bye-Laws require affirmative vote of majority of Board and majority of outstanding voting shares; specified provisions (voting, director election/removal, classified Board) require 66.67% shareholder vote. Amendments to Memorandum of Association require affirmative vote of majority of Board and 66.67% of outstanding voting shares.	NA	Makes it more difficult to amend provisions that may have an anti-takeover effect, reinforcing board control.
Business Combinations	Prohibited from engaging in business combinations with any interested shareholder (15% or more voting shares) for three years without Board and 66.67% non-interested shareholder approval, with certain exceptions.	NA	Acts as an anti-takeover measure, encouraging negotiation with the Board and protecting against hostile acquisitions.
Voting Rights Adjustments	Voting rights of any person's Controlled Shares (U.S. Person owning directly/indirectly 9.5% or more of votes) are reduced to less than 9.5% to avoid 9.5% Shareholder status. Board may also limit voting rights to avoid adverse tax, legal, or regulatory consequences.	NA	Prevents any single U.S. Person from exercising disproportionate voting control and helps manage regulatory compliance, but can reduce voting power for certain shareholders.
Consent to Special Actions	Requires prior written consent of Daniel S. Loeb for certain transactions with affiliates, shareholders, directors, officers, or employees, as long as he holds at least 25% of shares held on December 22, 2011.	2021-02-26	Grants significant influence to Daniel S. Loeb over certain related party transactions, potentially impacting corporate flexibility.
Board Oversight of Cybersecurity	The Board, in coordination with the Risk Capital Management Committee, oversees the company's risk management program, including cybersecurity threats. Regular presentations and reports are received on cybersecurity developments.	NA	Enhances oversight and governance of critical cybersecurity risks, aligning with increasing regulatory expectations.

Legal Proceedings

The company and its subsidiaries are subject to lawsuits and regulatory actions in the normal course of business, not directly arising from claims on reinsurance treaties or direct surplus lines insurance policies.
Business litigation may involve allegations of underwriting or claims-handling errors, disputes over delegated underwriting agreements, employment claims, regulatory actions, or disputes from business ventures.
Operating subsidiaries are subject to claims litigation involving disputed interpretations of policy coverages, with direct insurance operations facing greater frequency and diversity of claims litigation.
The company may engage in litigation or arbitration related to ceded reinsurance claims, including disputes challenging underwriting intent, which could result in protection providers not meeting obligations.
No individual litigation or arbitration is currently believed to have a material adverse effect on results of operations, financial condition, business, or operations.

Related Party Transactions

Insurance and reinsurance contracts with certain related parties resulted in gross written premium of $81.8 million in 2025 (2024: $99.1 million).
As of December 31, 2025, total receivables from these related parties were $86.4 million.
Investments managed by related parties totaled $770.6 million as of December 31, 2025, including Third Point Enhanced LP ($82.2 million), Third Point Insurance Solutions Fund I LLC ($1.6 million), Third Point Venture Offshore Fund I LP ($27.7 million), Third Point Venture Offshore Fund II LP ($6.3 million), and Third Point Optimized Credit Portfolio ($652.8 million).
Total management, advisory, and performance fees paid to related parties were $3.8 million in 2025 (2024: $5.4 million).
The company provided notice to Third Point LLC of its intent to redeem all capital accounts for TP Enhanced Fund on February 28, 2025.
The company notified Third Point LLC of its intention to withdraw investments from the Third Point Optimized Credit Portfolio by March 31, 2026, and terminate the existing investment management agreement.

Stakeholder Impact

**Shareholders**: Positive impact from increased net income, ROE, and book value per share. Potential for future dilution from capital raises. Redemption of Series B Preference Shares simplifies capital structure.
**Employees**: Continued focus on employee engagement, leadership development, and career progression. Workforce increased to 1,099 employees in 2025. Competitive compensation and benefits, including a global wellness day.
**Customers/Policyholders**: Strong financial strength ratings (A/ A3) enhance confidence in claims-paying ability. Strategic focus on specialty lines and MGA partnerships aims to offer diverse and tailored insurance solutions.
**Regulators**: Compliance with evolving regulatory frameworks in Bermuda, U.S., U.K., Sweden, and EU, including new tax laws (Bermuda CIT, GloBE Rules) and cybersecurity regulations. Maintenance of required statutory capital and solvency levels.
**Investment Professionals**: The company's investment strategy focuses on high-quality, fixed-income instruments, aiming to maximize risk-adjusted after-tax net investment income while maintaining liquidity and diversification.

Next Steps

Consolidate Assist America in consolidated financial statements in the first quarter of 2026.
Redeem all 8,000,000 issued and outstanding Series B Preference Shares on February 26, 2026.
Delist Series B Preference Shares from the NYSE and deregister them under the Securities Exchange Act of 1934 upon redemption.
Recognize a pre-tax gain of approximately $25.0 million in the first quarter of 2026 from the sale of Arcadian.
Initial closing on the majority of the World Nomads travel insurance business expected in the second or third quarter of 2026.
Final closing on the World Nomads travel insurance business expected in the second half of 2027.
File the group BSCR for the year ended December 31, 2025, with the BMA on or before May 31, 2026.
File statutory returns for SiriusPoint International and SGI for the year ended December 31, 2025, with the SFSA on or before July 30, 2026.
Establish a new investment management agreement to maintain access to Third Point's asset management services following withdrawal from the Third Point Optimized Credit Portfolio by March 31, 2026.

Key Dates

Date	Description
2011-10-06	Third Point Reinsurance Ltd. incorporated under Bermuda laws.
2011-10-10	SiriusPoint's Certificate of Incorporation issued.
2011-12-13	Certificates of Deposit of Memorandum of Increase in Share Capital issued.
2013-06-01	Third Point Reinsurance Ltd. listed on NYSE through IPO.
2013-08-08	Certificates of Deposit of Memorandum of Increase in Share Capital issued.
2017-09-22	Sirius Group issued SEK 2,750.0 million floating rate callable subordinated notes.
2018-11-05	Sirius Group issued Private Warrants to certain counterparties.
2018-11-28	Sirius Group issued Private Warrants to certain counterparties.
2021-02-26	SiriusPoint Ltd. formed through merger of Third Point Reinsurance Ltd. and Sirius International Insurance Group, Ltd. and Certificate of Incorporation amended. Series A Preference Shares issued. Merger Warrants issued. Company assumed Private Warrants. Investor Rights Agreement with Daniel S. Loeb dated.
2021-08-31	Series B Preference Shares dividend accrual began.
2021-11-30	First Dividend Payment Date for Series B Preference Shares.
2022-03-01	Approval from PRA to operate third country insurance branch for SiriusPoint International Insurance Corporation (publ) in the U.K. granted.
2022-09-22	2017 SEK Subordinated Notes became redeemable at company's option.
2022-12-01	Rob Gibbs' start date as CEO of SiriusPoint International.
2023-01-01	Banyan Risk Ltd. recapitalization completed, company ownership decreased to 49%.
2023-03-02	Agreement to enter into 2023 Loss Portfolio Transfer transaction with Pallas Reinsurance Company Ltd.
2023-06-30	2023 LPT closed, loss reserves reduced to $905.6 million.
2023-10-01	Company sold remainder of ownership in Banyan Risk Ltd. and deconsolidated.
2023-10-27	Sirius Group Public Warrants expired without exercise.
2023-11-05	All 5,418,434 Private Warrants exercised before maturity.
2023-12-27	Bermuda enacted the Corporate Income Tax Act 2023.
2024-01-01	GloBE Rules went into effect in the EU and other jurisdictions.
2024-04-05	Company issued $400.0 million aggregate principal amount of 7.0% Senior Notes due 2029.
2024-06-30	Company deconsolidated Arcadian Risk Capital Ltd. due to loss of controlling interest.
2024-08-01	Company entered into Confidential Settlement and Mutual Release Agreement and Share Repurchase Agreement with CM Bermuda Limited.
2024-10-01	SiriusPoint America and Clarendon National Insurance Company entered into 2024 Loss Portfolio Transfer Reinsurance Agreement.
2024-12-19	Company entered into a 4-year, $400.0 million senior unsecured revolving credit facility with JPMorgan Chase Bank, N.A.
2024-12-30	Company entered into Securities Purchase Agreement with CM Bermuda to repurchase common shares and warrants.
2025-01-01	Bermuda Corporate Income Tax Act 2023 took effect. Personal Information Protection Act 2016 (PIPA) fully implemented in Bermuda.
2025-02-27	Closing of the CM Bermuda Securities Purchase Agreement, repurchasing all common shares and warrants held by CM Bermuda.
2025-09-25	SiriusPoint America approved as a new member to the Federal Home Loan Bank of New York (FHLBNY).
2025-09-29	Agreement to sell wholly-owned subsidiary ArmadaCorp Capital, LLC to Ambac Financial Group Inc. for $250 million.
2025-10-03	Agreement to sell 49% equity stake in Arcadian to Lee Equity Partners for $140.4 million.
2025-10-31	Sale of ArmadaCorp Capital, LLC closed; deconsolidated effective November 1, 2025.
2025-12-31	Fiscal year ended. Agreement to acquire Assist America entered into.
2026-01-01	Control of Assist America effective. All-natural perils excess of loss reinsurance coverage for property reinsurance exposures in place.
2026-01-05	Company offered remaining holders of Series A Preference Shares opportunity to convert to common equity.
2026-01-29	Company announced redemption of all outstanding Series B Preference Shares.
2026-01-30	Sale of 49% equity stake in Arcadian to Lee Equity Partners closed.
2026-02-12	Sirius International UK Holdings II Ltd entered into purchase agreement to acquire World Nomads travel insurance business.
2026-02-19	As of this date, 116,990,288 common shares were issued and outstanding.
2026-02-24	Date of filing of the Annual Report on Form 10-K.
2026-02-26	Redemption Date for Series B Preference Shares.
2026-05-31	Deadline for filing group BSCR for the year ended December 31, 2025, with the BMA.
2026-07-30	Deadline for filing statutory returns for SiriusPoint International and SGI for the year ended December 31, 2025, with the SFSA.
2026-12-15	Effective date for ASU 2024-03 (Income Statement Expenses) for annual reporting periods beginning after this date.
2027-12-15	Effective date for ASU 2025-06 (Internal-Use Software) for annual reporting periods beginning after this date.

Recommendation

strong buy

SiriusPoint's 2025 annual report demonstrates a significant turnaround and strong execution of its strategic transformation. The substantial increase in net income and return on equity, coupled with disciplined underwriting leading to a healthy combined ratio, indicates robust operational performance. The successful divestiture of non-core assets and strategic acquisitions like Assist America, along with the planned redemption of Series B Preference Shares, highlight effective capital management and a commitment to simplifying the capital structure. While the reinsurance market faces some headwinds, the company's diversified business model, focus on specialty lines, and strong MGA partnerships position it for continued profitable growth. The improved financial metrics and clear strategic direction make this an attractive investment opportunity for long-term value creation.

Keywords

Reinsurance, Insurance, Specialty Underwriter, MGA, Accident & Health, Property & Casualty, Investment Portfolio, Capital Management, SEC Filing, Financial Results, Risk Management, Corporate Governance, Bermuda, NYSE, SPNT

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.